Åsne
Jul-Larsen
Chief Engineer
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 55 97 49 29
+47 414 79 239
E-mail:
Journal articles
- 2012. The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants. Human Vaccines & Immunotherapeutics. 8: 653-661. doi: 10.4161/hv.19503
- 2012. The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses. 6: 90-100. doi: 10.1111/j.1750-2659.2011.00271.x
- 2010. Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein. BMC Molecular Biology. 11. 12 pages. doi: 10.1186/1471-2199-11-89
- 2010. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine. 29: 266-273. doi: 10.1016/j.vaccine.2010.10.038
- 2009. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins. Journal of Cell Science. 122: 1201-1210. doi: 10.1242/jcs.040840
- 2007. Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres. Nucleic Acids Research. 35: 7267-7278. doi: 10.1093/nar/gkm738
- 2007. Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres. Nucleic Acids Research. 35: 7267-7278.
- 2006. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA. Journal of Cell Science. 119: 3284-3295. doi: 10.1242/jcs.03068
Reports and theses
- 2008. Promyelocytic leukaemia protein (PML) – functions inside and outside the PML-nuclear bodies.
More information in national current research information system (CRIStin)